OTC · CRXM
Gene Biotherapeutics, Inc.
$0.00+$0.00 (+9,900.0%)
Gene Biotherapeutics, Inc.: Healthcare · Biotechnology.
Loading market information…
OTC · GTHR · USD
Stock price
Quote as of Mar 10, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
GeneThera, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.33% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
GeneThera, Inc. is a biotechnology firm dedicated to crafting advanced diagnostic tools and therapeutic solutions for diseases that can transfer from animals to humans (zoonotic diseases). The company's portfolio includes treatments for a variety of these conditions, such as COVID-19, and illnesses like paratuberculosis (Johne's disease), currently in its Stage III clinical phase, as well as mad cow and chronic wasting diseases, and common bacterial infections like E.coli and salmonella. Furthermore, GeneThera is developing a vaccine specifically targeting Mycobacterium avium subspecies paratuberculosis bacteria. Utilizing its innovative Molecular Robotic/AI Platform and a strategic therapeutic framework, the company strives to inhibit the spread of animal-borne diseases and improve control over zoonotic infectious agents. GeneThera, Inc. operates out of Westminster, Colorado.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:19 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00+$0.00 (+9,900.0%)
Gene Biotherapeutics, Inc.: Healthcare · Biotechnology.
$0.00-$0.04 (-99.75%)
American CryoStem Corporation: Healthcare · Biotechnology.
$0.00+$0.00 (+1,000.0%)
Allied Healthcare Products, Inc.: Healthcare · Medical - Devices.
$0.00$0.00 (0.0%)
ER Urgent Care Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.39% below the high.
$0.00$0.00 (0.0%)
DermTech, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.83% below the high.
$0.00$0.00 (0.0%)
Lescarden Inc.: Healthcare · Biotechnology.
$0.00$0.00 (0.0%)
Tauriga Sciences, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00-$0.00 (-99.0%)
EPIRUS Biopharmaceuticals, Inc.: Healthcare · Biotechnology.
